Skip to content

Clinical trials

COVID-19 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: Germany Clear all

218 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20182
2020105
202157
202235
20235
20247
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed116
Unknown status40
Terminated31
Recruiting17
Active, not recruiting6
Withdrawn5
Suspended1
No longer available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital Tuebingen15
Charite University, Berlin, Germany12
Universitätsklinikum Hamburg-Eppendorf9
AstraZeneca7
BioNTech SE7
Hannover Medical School4
Novartis Pharmaceuticals4
University of Giessen4
CureVac3
Dr. Alexander Supady3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19218
Coronavirus Infections21
Post-Acute COVID-19 Syndrome11
Severe Acute Respiratory Syndrome11
Anxiety Disorders8
Critical Illness8
Respiratory Tract Infections8
Virus Diseases8
Pneumonia7
Respiratory Distress Syndrome7

Trials

Showing 1 to 25 of 218. Each trial links to its page on Pharma Observatory.

118 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.